ARCIELLO, ANGELA
 Distribuzione geografica
Continente #
EU - Europa 3.617
AS - Asia 3.424
NA - Nord America 3.013
SA - Sud America 457
AF - Africa 118
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 1
Totale 10.633
Nazione #
US - Stati Uniti d'America 2.906
SG - Singapore 1.785
RU - Federazione Russa 1.450
IT - Italia 1.199
CN - Cina 829
BR - Brasile 384
VN - Vietnam 302
DE - Germania 293
HK - Hong Kong 236
FI - Finlandia 132
NL - Olanda 128
IN - India 78
FR - Francia 74
GB - Regno Unito 65
IE - Irlanda 65
CA - Canada 59
CI - Costa d'Avorio 50
UA - Ucraina 44
ZA - Sudafrica 39
BD - Bangladesh 34
PL - Polonia 33
SE - Svezia 33
KR - Corea 31
JP - Giappone 27
MX - Messico 26
AR - Argentina 24
ES - Italia 23
EC - Ecuador 18
AT - Austria 15
TR - Turchia 14
IR - Iran 13
CZ - Repubblica Ceca 10
ID - Indonesia 10
IL - Israele 10
PK - Pakistan 10
AE - Emirati Arabi Uniti 9
CH - Svizzera 9
IQ - Iraq 9
LT - Lituania 9
MA - Marocco 8
VE - Venezuela 8
CO - Colombia 7
BE - Belgio 6
BG - Bulgaria 6
EG - Egitto 6
KE - Kenya 5
CL - Cile 4
PA - Panama 4
PT - Portogallo 4
PY - Paraguay 4
UZ - Uzbekistan 4
AL - Albania 3
DO - Repubblica Dominicana 3
NP - Nepal 3
PS - Palestinian Territory 3
RS - Serbia 3
UY - Uruguay 3
AZ - Azerbaigian 2
BN - Brunei Darussalam 2
CG - Congo 2
CR - Costa Rica 2
DK - Danimarca 2
HN - Honduras 2
HU - Ungheria 2
JM - Giamaica 2
KG - Kirghizistan 2
LC - Santa Lucia 2
PE - Perù 2
SA - Arabia Saudita 2
SN - Senegal 2
TH - Thailandia 2
AU - Australia 1
BO - Bolivia 1
BZ - Belize 1
CU - Cuba 1
DM - Dominica 1
EE - Estonia 1
ET - Etiopia 1
GH - Ghana 1
GR - Grecia 1
GT - Guatemala 1
GY - Guiana 1
HR - Croazia 1
HT - Haiti 1
IM - Isola di Man 1
IS - Islanda 1
JO - Giordania 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
LU - Lussemburgo 1
LV - Lettonia 1
MD - Moldavia 1
MN - Mongolia 1
MQ - Martinica 1
MW - Malawi 1
MY - Malesia 1
NC - Nuova Caledonia 1
NZ - Nuova Zelanda 1
OM - Oman 1
PH - Filippine 1
Totale 10.626
Città #
Singapore 822
Chandler 436
Moscow 385
Ashburn 313
Naples 284
Beijing 276
Hong Kong 229
Napoli 184
Santa Clara 148
Hefei 128
San Jose 116
Amsterdam 104
Ho Chi Minh City 98
Los Angeles 89
Munich 85
Millbury 81
New York 64
Nanjing 57
Boston 52
Hanoi 51
Princeton 50
Buffalo 44
Turku 41
São Paulo 39
Dallas 38
Helsinki 38
Jacksonville 37
Dong Ket 36
Seattle 34
Falkenstein 30
Frankfurt am Main 30
Des Moines 29
Milan 29
Lawrence 28
Redondo Beach 28
Rome 25
Seoul 25
Hyderabad 24
The Dalles 24
Warsaw 23
Johannesburg 21
Ottawa 20
Tokyo 20
Chennai 19
Denver 19
Nuremberg 19
Phoenix 19
Brooklyn 18
Chicago 18
Düsseldorf 18
Rio de Janeiro 18
Hebei 16
Redwood City 16
Shenyang 16
Haiphong 15
Orem 15
Stockholm 15
London 14
Tianjin 14
Wilmington 14
Woodbridge 14
Nanchang 13
Ann Arbor 12
Lappeenranta 12
Montreal 12
Bari 11
Caserta 11
Guangzhou 11
Lauterbourg 11
Mexico City 11
Poplar 11
Pune 11
Toronto 11
Washington 11
Atlanta 10
Bacoli 10
Portici 10
San Francisco 10
Ankara 9
Biên Hòa 9
Houston 9
Jinan 9
San Giorgio a Cremano 9
Belo Horizonte 8
Brasília 8
Bắc Ninh 8
Changsha 8
Da Nang 8
Falls Church 8
Karlsruhe 8
Ninh Bình 8
Norwalk 8
Quito 8
Roubaix 8
Afragola 7
Castellammare Di Stabia 7
Dublin 7
Fairfield 7
Hải Dương 7
Jiaxing 7
Totale 5.375
Nome #
Cryptic antimicrobial peptides, a still unexploited source of bioactive peptides 250
Femtosecond UV-laser pulses to unveil protein-protein interactions in living cells 195
Novel human bioactive peptides identified in Apolipoprotein B: Evaluation of their therapeutic potential 193
3D GRID-based pharmacophore and Metadynamics approaches for the rational design of N-Methyl β-sheet breaker peptides as inhibitors of the Alzheimer's Aβ-amyloid fibrillogenesis 191
Insights into the anticancer properties of the first antimicrobial peptide from Archaea 165
A new cryptic host defense peptide identified in human 11-hydroxysteroid dehydrogenase 1 -like: from in silico identification to experimental evidence 158
Human Cryptic Host Defence Peptides: identification and analysis of their antimicrobial, anti-biofilm and immunomodulatory properties 157
Protective Effects of Recombinant Human Angiogenin in Keratinocytes: New Insights on Oxidative Stress Response Mediated by RNases 149
Protein conformational perturbations in hereditary amyloidosis: Differential impact of single point mutations in ApoAI amyloidogenic variants 146
A powerful in silico approach allowed the identification of a new antimicrobial peptide from the third domain of life 146
Edible Films Made of Dried Olive Leaf Extract and Chitosan: Characterization and Applications 143
Fighting multidrug resistance with a fruit extract: anti-cancer and anti-biofilm activities of Acca sellowiana 139
Cryptides Identified in Human Apolipoprotein B as New Weapons to Fight Antibiotic Resistance in Cystic Fibrosis Disease 136
Human Cryptic Host Defence Peptide GVF27 Exhibits Anti-Infective Properties against Biofilm Forming Members of the Burkholderia cepacia Complex 135
Identification of novel direct protein-protein interactions by irradiating living cells with femtosecond UV laser pulses 134
Cost-effective production of recombinant peptides in Escherichia coli 133
Development and characterization of antimicrobial and antioxidant whey protein-based films functionalized with Pecan (Carya illinoinensis) nut shell extract 132
Enzymatically active fibrils generated by self-assembly of the ApoA-I fibrillogenic domain functionalized with a catalytic moiety. 127
Apolipoprotein A-I amyloidogenic variant L174S, expressed and isolated from stably transfected mammalian cells, is associated with fatty acids 127
Tailoring the stress response of human skin cells by substantially limiting the nuclear localization of angiogenin 126
Synthetic Antibiotic Derived from Sequences Encrypted in a Protein from Human Plasma 126
Catalytic fibrils, a nanoscale biomaterial generated by amyloid fibrils functionalized with an enzyme 125
Novel human antimicrobial peptides from ApoB are endowed with promising anti-inflammatory properties 125
All natural mussel-inspired bioadhesives from soy proteins and plant derived polyphenols with marked water-resistance and favourable antibacterial profile for wound treatment applications 124
Insights into Carbonic Anhydrase VII functional role 123
Human apolipoprotein E as a reservoir of cryptic bioactive peptides: The case of ApoE 133-167 123
Improved shelf-life of Nabulsi cheese wrapped with hydrocolloid films 123
Insights into the interaction of the N-terminal amyloidogenic polypeptide of ApoA-I with model cellular membranes 122
Biocompatibility, uptake and endocytosis pathways of polystyrene nanoparticles in primary human renal epithelial cells. 122
The 93-residue N-terminal domain of apolipoprotein A-I (ApoA-I), responsible for amyloid formation, is a cytotoxic agent. 120
Host defense peptides identified in human apolipoprotein B as natural food bio-preservatives: Evaluation of their biosafety and digestibility 117
Amyloidoses associated to Apolipoprotein A-I: analysis of the molecular bases of the disease 116
Development and properties of new chitosan-based films plasticized with spermidine and/or glycerol 116
A proteomic approach to investigate the effects of cadmium and lead on human primary renal cells. 115
Environment‐sensitive fluorescent labelling of peptides by luciferin analogues 111
Toxicity and membrane perturbation properties of the ribotoxin-like protein Ageritin 110
Rapid detection of Candida albicans in urine by an Electrochemical Impedance Spectroscopy (EIS)-based biosensor 110
Immunotoxins and ImmunoRNases 109
Transglutaminase-mediated crosslinking of a host defence peptide derived from human apolipoprotein B and its effect on the peptide antimicrobial activity 109
Synthesis, biological evaluation and metadynamics simulations of novel N-methyl β-sheet breaker peptides as inhibitors of Alzheimer's β-amyloid fibrillogenesis 108
Expression and characterization of recombinant apolipoprotein A-I (ApoA-I) fibrillogenic domain: first steps towards a structural and functional definition of ApoA-I associated amyloidosis 108
Effects of human antimicrobial cryptides identified in apolipoprotein B depend on specific features of bacterial strains 107
Recombinant amyloidogenic domain of ApoA-I: analysis of its fibrillogenic potential 106
Human carbonic anhydrase VII protects cells from oxidative damage 105
Human Antitumor RNases and ImmunoRNases 104
Expression of human apolipoprotein A-I in Nicotiana tabacum 104
Human Carbonic Anhydrase VII protects cells from oxidative damage 104
Controlled Pore Glass-based oligonucleotide affinity support: towards High Throughput Screening methods for the identification of conformation-selective G-quadruplex ligands 104
Apolipoprotein A-I associated amyloidoses: the intriguing case of a natively unfolded protein fragment. 103
Screen printed based impedimetric immunosensor for rapid detection of Escherichia coli in drinking water 103
Cytotoxicity of an innovative pressurised cyclic solid–liquid (Pcsl) extract from artemisia annua 103
Physicochemical and antimicrobial properties of whey protein-based films functionalized with palestinian Satureja capitata essential oil 103
Nuclear and plastidial expression of the gene encoding human apolipoprotein ApoA.I in tobacco 102
Amyloidogenic variant of apolipoprotein A-I elicits cellular stress by attenuating the protective activity of angiogenin 102
Cell milieu significantly affects the fate of AApoAI amyloidogenic variants: predestination or serendipity? 102
Bioactive protein-based films containing an antimicrobial apolipoprotein B fragment. 102
Unveiling Molecular Recognition of Sialoglycans by Human Siglec-10 102
Two series of benzofuran and benzodifuran chelating chromophores with DR/NIR emission and anticancer activity 101
Expression of ApoA-I human apolipoprotein mutants in tobacco plants 101
Antineoplastic ribonucleases selectively kill thyroid carcinoma cells via caspase-mediated induction of apoptosis 100
Insights into the fate of the N-terminal amyloidogenic polypeptide of ApoA-I in cultured target cells. 100
Tuning the polymorphism of the anti-VEGF G-rich V7t1 aptamer by covalent dimeric constructs 100
Dna binding mode analysis of a core-extended naphthalene diimide as a conformation-sensitive fluorescent probe of g-quadruplex structures 100
Host Defence Cryptides from Human Apolipoproteins: Applications in Medicinal Chemistry 99
Exploring the Binding of Natural Compounds to Cancer-Related G-Quadruplex Structures: From 9,10-Dihydrophenanthrenes to Their Dimeric and Glucoside Derivatives 97
Effects of a lipid environment on the fibrillogenic pathway of the N-terminal polypeptide of human apolipoprotein A-I, responsible for in vivo amyloid fibril formation 97
Effects of iron on the aggregation propensity of the N-terminal fibrillogenic polypeptide of human apolipoprotein A-I 96
IMMUNORNASES AS ANTITUMOUR AGENTS 95
Amyloidoses associated to apolipoprotein A-I: The intriguing case of a natively unfolded protein fragment 95
Binding, internalization and extracellular route of the fibrillogenic fragment of ApoA-I in cardiomyoblasts 95
Structural features for the mechanism of antitumor action of a dimeric human pancreatic ribonuclease variant 93
Human, Anti-ErbB2 Antitumor Immunoagents 92
Novel bioactive peptides from PD-L1/2, a type 1 ribosome inactivating protein from Phytolacca dioica L. Evaluation of their antimicrobial properties and anti-biofilm activities 92
Host defence peptides identified in human apolipoprotein B as promising antifungal agents 92
KNR50: a moonlighting bioactive peptide hidden in the C-terminus of bovine casein αS2 with powerful antimicrobial, antibiofilm, antiviral and immunomodulatory activities 91
Analysis of ATP-binding cassette transporter expression in drug-selected cell lines by a microarray dedicated to multidrug resistance 90
Selective light-up of dimeric G-quadruplex forming aptamers for efficient VEGF165 detection 89
null 89
Novel Antimicrobial Strategies to Prevent Biofilm Infections in Catheters after Radical Cystectomy: A Pilot Study 89
A fully human antitumor immunoRNase selective for ErbB-2-positive carcinomas. 89
Fibrillogenesis of ApoA-1 1-93: Identification of an intermediate with a collapsed and partially folded conformation 89
Loading of Polydimethylsiloxane with a Human ApoB-Derived Antimicrobial Peptide to Prevent Bacterial Infections 89
Effects of the known pathogenic mutations on the aggregation pathway of the amyloidogenic Peptide of apolipoprotein a-I. 85
Host defense peptides identified in human apolipoprotein B as novel food biopreservatives and active coating components 85
Ribonucleases as Antitumor Agents 84
Novel Retro-Inverso Peptide Antibiotic Efficiently Released by a Responsive Hydrogel-Based System 82
ImmunoRNases as antitumor agents 79
Modular symmetric ligands for selective recognition of cancer-relevant G-quadruplexes 78
A DR/NIR Hybrid Polymeric Tool for Functional Bio-Coatings: Theoretical Study, Cytotoxicity, and Antimicrobial Activity 78
Predicting drug sensitivity and resistance: profiling ABC transporter genes in cancer cells 77
Fully Human Anti-Cancer ImmunoAgents 77
Antimicrobial and antibiofilm activity of specialized metabolites isolated from Centaurea hyalolepis 72
Inflammation protein quantification by multiple reaction monitoring mass spectrometry in lipopolysaccharide-stimulated THP-1 cells 70
Effects of disease-associated mutations on the aggregation process of the 93-residue N-terminal fragment of human apolipoprotein A-I 70
Apolipoprotein A-I: the dual face of a protein 70
Impact of a single point mutation on the antimicrobial and fibrillogenic properties of cryptides from human apolipoprotein B 67
When annealing is detrimental: The case of HMGB1-targeting G-quadruplex aptamers 60
Dual-action thioarylamide-based small molecules to target drug-resistant bacteria and chronic inflammation 28
Covalently linked dimers of a G-quadruplex-forming aptamer as HMGB1 inhibitors 25
Enzymatically Crafted Bacterial Cellulose Nanoparticles Functionalized With Antimicrobial Peptides: Toward Sustainable Antimicrobial Formulations 24
Totale 10.771
Categoria #
all - tutte 33.317
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 33.317


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021192 0 0 0 0 0 0 16 40 20 10 63 43
2021/2022618 6 5 7 28 14 7 6 18 121 50 143 213
2022/20231.100 116 127 50 69 113 111 56 94 185 111 56 12
2023/2024721 35 110 62 44 49 92 51 96 18 21 90 53
2024/20253.276 135 87 26 53 114 194 332 211 233 347 1.266 278
2025/20263.913 644 416 595 652 1.198 270 138 0 0 0 0 0
Totale 10.846